World Journal of
Pharmaceutical and Life Sciences

CORONAVIRUS 2 (COVID-19): EPIDEMIC DISEASE - A REVIEW

Prof. M. H. Fulekar*, Radhey Shyam Kaushal, Jyoti Fulekar and Gangawane A. K.

ABSTRACT

Coronavirus-2 belongs to coronaviridae family; the first known severe illness caused by corona virus emerges (2003) as SARS in China followed by second outbreak of severe illness began (2012) as MERS in Saudi Arabia. Further, in December 2019 corona virus outbreak was initiated from the animal such as bat, frogs, snakes, birds, marmots and rabbits and transfer to human being from human seafood market in Wuhan city of China and spread to whole world. The National Health Commission China (Jan 12th, 2020) released coronavirus as epidemic with sign and symptomsfever, dry cough, running nose, sore throat etc. Now coronavirus-2 epidemic disease spread from China to USA and throughout the world. Coronavirus-2 epidemic infected number of peoples, few are recovered and many peoples are died. The data available online in respect to Indian scenario has been highlighted. World Health Organization recommended drugs: Remdesivir, Chloroquine and hydroxychloroquine, Lopinavir and Ritonavir. However, there is no specific drug or vaccines available for coronavirus-2 disease. The leading research Institutes/Universities working on the invention of coronavirus-2 drug throughout the world. In view of the severity of the coronavirus-2 epidemic to pandemic the present paper has highlighted the origin of coronavirus-2 disease, transmission, entry to the human body, mechanism of human coronavirus-2, epidemiology and pathology. WHO report on coronavirus-2 in brief, their potential therapeutic measures including Indian Ayurvedic – prevention measures as well as precautionary measures suggested by scientist are reviewed as a reference material for further studies.

[Full Text Article]   [Download Certificate]